Short-term oestrogen as a strategy to prevent postpartum depression in high-risk women: protocol for the double-blind, randomised, placebo-controlled MAMA clinical trial

INTRODUCTION: Postpartum depression affects 10%–15% of women and has a recurrence rate of 40% in subsequent pregnancies. Women who develop postpartum depression are suspected to be more sensitive to the rapid and large fluctuations in sex steroid hormones, particularly estradiol, during pregnancy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Høgh, Stinne, Hegaard, Hanne Kristine, Renault, Kristina Martha, Cvetanovska, Eleonora, Kjærbye-Thygesen, Anette, Juul, Anders, Borgsted, Camilla, Bjertrup, Anne Juul, Miskowiak, Kamilla Woznica, Væver, Mette Skovgaard, Stenbæk, Dea Siggaard, Dam, Vibeke Høyrup, Binder, Elisabeth, Ozenne, Brice, Mehta, Divya, Frokjaer, Vibe G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Mental Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719185/
https://www.ncbi.nlm.nih.gov/pubmed/35763351
http://dx.doi.org/10.1136/bmjopen-2021-052922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719185/
https://www.ncbi.nlm.nih.gov/pubmed/35763351
http://dx.doi.org/10.1136/bmjopen-2021-052922

Ejemplares similares